Veea Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 12, 2026, reporting financial results for the three and nine months ended September 30, 2026.
Key Highlights
- Quarterly net loss: Veea reported a net loss of $3,659,587 for the three months ended September 30, 2026, compared to net income of $1,375,294 in the same quarter of 2025.
- Nine-month net loss: For the nine months ended September 30, 2026, the company reported a net loss of $12,358,543, versus a net loss of $1,736,512 for the same period in 2025.
- Quarterly revenue: Net sales were $72,135 for Q3 2026, down from $144,926 in Q3 2025; nine-month net sales were $428,773 versus $232,094 a year earlier.
- Total assets and equity: Total assets were $29,830,783 as of September 30, 2026, and total stockholders' equity was $5,847,894, compared to a stockholders' deficit of $(9,751,880) at December 31, 2025.
- Accumulated deficit: The accumulated deficit stood at $236,849,099 as of September 30, 2026, up from $224,490,556 at December 31, 2025.
- Shares outstanding: As of November 10, 2026, there were 4,071,515 shares of common stock issued and outstanding.
- Revolving credit line retired: The revolving line of credit balance was $0 at September 30, 2026, down from $14,000,000 at December 31, 2025.
Veea Inc. Financial Results for the Quarter and Nine Months Ended September 30, 2026
According to the filing, Veea Inc. (NASDAQ:VEEA) recorded a net loss of $3,659,587 for the three months ended September 30, 2026, a reversal from the net income of $1,375,294 reported in the same period a year prior. The company disclosed that the prior-year quarter benefited from significant non-cash gains, including a $4,720,000 change in fair value of the earn-out share liability and a $1,223,328 UK R&D tax credit, neither of which recurred in the current quarter. For the nine months ended September 30, 2026, the registrant reported a net loss of $12,358,543, compared to a net loss of $1,736,512 for the same period in 2025.
The filing shows that net sales for Q3 2026 were $72,135, a decline from $144,926 in Q3 2025. Nine-month net sales totaled $428,773, up from $232,094 in the prior-year period. Total operating expenses for the nine months ended September 30, 2026 were $16,546,994, with general and administrative expenses comprising the largest component at $14,771,974. The company reported a loss from operations of $4,016,626 for the third quarter and $16,191,726 for the nine-month period, according to the filing.
On the balance sheet, total assets were $29,830,783 as of September 30, 2026, compared to $28,220,625 at December 31, 2025. The registrant disclosed that total liabilities decreased to $23,982,889 from $37,972,505 at year-end 2025, with the revolving line of credit fully eliminated and earn-out share liability reduced to $346,200 from $2,543,600. Total stockholders' equity shifted to a positive $5,847,894 from a deficit of $(9,751,880) at December 31, 2025. As of September 30, 2026, the company had 253,329 shares of Series A Convertible Preferred Stock and 3,818,055 shares of common stock issued and outstanding.
What Was Disclosed
Veea Inc. filed its Q3 2026 Form 10-Q disclosing a net loss of $3,659,587 for the quarter and $12,358,543 for the nine-month period, alongside a shift to positive stockholders' equity of $5,847,894 and elimination of its $14,000,000 revolving credit line.




Please wait processing your request...